Correlation Between Sangamo Therapeutics and Heron Therapeuti
Can any of the company-specific risk be diversified away by investing in both Sangamo Therapeutics and Heron Therapeuti at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sangamo Therapeutics and Heron Therapeuti into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sangamo Therapeutics and Heron Therapeuti, you can compare the effects of market volatilities on Sangamo Therapeutics and Heron Therapeuti and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sangamo Therapeutics with a short position of Heron Therapeuti. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sangamo Therapeutics and Heron Therapeuti.
Diversification Opportunities for Sangamo Therapeutics and Heron Therapeuti
-0.65 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Sangamo and Heron is -0.65. Overlapping area represents the amount of risk that can be diversified away by holding Sangamo Therapeutics and Heron Therapeuti in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Heron Therapeuti and Sangamo Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sangamo Therapeutics are associated (or correlated) with Heron Therapeuti. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Heron Therapeuti has no effect on the direction of Sangamo Therapeutics i.e., Sangamo Therapeutics and Heron Therapeuti go up and down completely randomly.
Pair Corralation between Sangamo Therapeutics and Heron Therapeuti
Given the investment horizon of 90 days Sangamo Therapeutics is expected to under-perform the Heron Therapeuti. But the stock apears to be less risky and, when comparing its historical volatility, Sangamo Therapeutics is 2.02 times less risky than Heron Therapeuti. The stock trades about -0.23 of its potential returns per unit of risk. The Heron Therapeuti is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest 184.00 in Heron Therapeuti on September 12, 2024 and sell it today you would lose (15.00) from holding Heron Therapeuti or give up 8.15% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Sangamo Therapeutics vs. Heron Therapeuti
Performance |
Timeline |
Sangamo Therapeutics |
Heron Therapeuti |
Sangamo Therapeutics and Heron Therapeuti Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Sangamo Therapeutics and Heron Therapeuti
The main advantage of trading using opposite Sangamo Therapeutics and Heron Therapeuti positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sangamo Therapeutics position performs unexpectedly, Heron Therapeuti can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Heron Therapeuti will offset losses from the drop in Heron Therapeuti's long position.Sangamo Therapeutics vs. Editas Medicine | Sangamo Therapeutics vs. Intellia Therapeutics | Sangamo Therapeutics vs. Bluebird bio | Sangamo Therapeutics vs. Alnylam Pharmaceuticals |
Heron Therapeuti vs. Mereo BioPharma Group | Heron Therapeuti vs. Terns Pharmaceuticals | Heron Therapeuti vs. PDS Biotechnology Corp | Heron Therapeuti vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Complementary Tools
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |